HOMATROPINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Homatropine, and when can generic versions of Homatropine launch?
Homatropine is a drug marketed by Actavis Elizabeth, Avanthi Inc, and Novel Labs Inc. and is included in three NDAs.
The generic ingredient in HOMATROPINE is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Homatropine
A generic version of HOMATROPINE was approved as homatropine methylbromide; hydrocodone bitartrate by AVANTHI INC on August 7th, 2017.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HOMATROPINE?
- What are the global sales for HOMATROPINE?
- What is Average Wholesale Price for HOMATROPINE?
Summary for HOMATROPINE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| DailyMed Link: | HOMATROPINE at DailyMed |
US Patents and Regulatory Information for HOMATROPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Elizabeth | HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE | homatropine methylbromide; hydrocodone bitartrate | TABLET;ORAL | 040295-001 | Dec 1, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Avanthi Inc | HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE | homatropine methylbromide; hydrocodone bitartrate | TABLET;ORAL | 207176-001 | Aug 7, 2017 | AA | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Novel Labs Inc | HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE | homatropine methylbromide; hydrocodone bitartrate | TABLET;ORAL | 091528-001 | Apr 20, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
